|
| 36796442 | Retinal characteristics in eyes with pathologic myopia among individuals self-identifying as Black. | Can J Ophthalmol | 2024 |
| 34656987 | Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes. | Br J Ophthalmol | 2023 |
| 37499953 | High Myopia Normative Database of Peripapillary Retinal Nerve Fiber Layer Thickness to Detect Myopic Glaucoma in a Chinese Population. | Ophthalmology | 2023 |
| 36951873 | JAMA Ophthalmology-The Year in Review, 2022: Continued Evolution for Readers, Authors, and Editors. | JAMA Ophthalmol | 2023 |
| 37289463 | Accuracy of Artificial Intelligence in Estimating Best-Corrected Visual Acuity From Fundus Photographs in Eyes With Diabetic Macular Edema. | JAMA Ophthalmol | 2023 |
| 36977936 | Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema. | Eye (Lond) | 2023 |
| 37103930 | What Artificial Intelligence Chatbots Mean for Editors, Authors, and Readers of Peer-Reviewed Ophthalmic Literature. | JAMA Ophthalmol | 2023 |
| 36520462 | Immunogenicity With Ranibizumab Biosimilar SB11 (Byooviz) and Reference Product Lucentis and Association With Efficacy, Safety, and Pharmacokinetics: A Post Hoc Analysis of a Phase 3 Randomized Clinical Trial. | JAMA Ophthalmol | 2023 |
| 36516051 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Intern Med | 2023 |
| 36516049 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA | 2023 |
| 36516048 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Neurol | 2023 |
| 36516046 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Oncol | 2023 |
| 36516043 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Surg | 2023 |
| 36516044 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Pediatr | 2023 |
| 36516039 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Psychiatry | 2023 |
| 36516037 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 36516038 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Dermatol | 2023 |
| 36516036 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Ophthalmol | 2023 |
| 36516027 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Cardiol | 2023 |
| 34848169 | Correlation of Change in Central Subfield Thickness and Change in Visual Acuity in Neovascular AMD: Post Hoc Analysis of VIEW 1 and 2. | Am J Ophthalmol | 2022 |
| 35543680 | The NEI VFQ-25C: Calibrating Items in the National Eye Institute Visual Function Questionnaire-25 to Enable Comparison of Outcome Measures. | Transl Vis Sci Technol | 2022 |
| 35594036 | Scleral Cross-Linking in Form-Deprivation Myopic Guinea Pig Eyes Leads to Glaucomatous Changes. | Invest Ophthalmol Vis Sci | 2022 |
| 35748935 | Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT. | Graefes Arch Clin Exp Ophthalmol | 2022 |
| 37007927 | Correlation of Change in Macular Thickness With Change in Visual Acuity in Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials. | J Vitreoretin Dis | 2022 |
| 36516025 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Health Forum | 2022 |
| 36516024 | Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. | JAMA Netw Open | 2022 |
| 36179334 | Optical Coherence Tomography Features for Identifying Posttreatment Complete Polypoidal Regression in Polypoidal Choroidal Vasculopathy. | Asia Pac J Ophthalmol (Phila) | 2022 |
| 35952753 | Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration. | Am J Ophthalmol | 2022 |
| 33781929 | Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy. | Ophthalmol Retina | 2022 |
| 34967890 | Detecting Anomalies in Retinal Diseases Using Generative, Discriminative, and Self-supervised Deep Learning. | JAMA Ophthalmol | 2022 |
| 35323855 | JAMA Ophthalmology-The Year in Review, 2021: Fact and Opinion. | JAMA Ophthalmol | 2022 |
| 33410918 | Express Medicine-Potential for Home-Based Medical Care. | JAMA Ophthalmol | 2021 |
| 37008702 | Patient Use of Dietary Supplements, Home Monitoring, or Genetic Testing for Nonneovascular Age-Related Macular Degeneration. | J Vitreoretin Dis | 2021 |
| 36218750 | Equity and the JAMA Network. | JAMA Health Forum | 2021 |
| 33713680 | Costs of Managing Diabetic Macular Edema With Good Visual Acuity With Aflibercept, Laser, or Observation: DRCR Retina Network Protocol V. | Am J Ophthalmol | 2021 |
| 33764363 | JAMA Ophthalmology-The Year in Review, 2020: Bringing Focus to Randomized Clinical Trials. | JAMA Ophthalmol | 2021 |
| 33914021 | Biosimilar Ranibizumab (SB11) vs Reference Ranibizumab-Diving Deeper for Safety and Efficacy-Reply. | JAMA Ophthalmol | 2021 |
| 34419979 | Prevention of vision-threatening complications in diabetic retinopathy: two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA. | Curr Opin Ophthalmol | 2021 |
| 34003898 | Addressing Artificial Intelligence Bias in Retinal Diagnostics. | Transl Vis Sci Technol | 2021 |
| 34081110 | Equity and the JAMA Network. | JAMA Netw Open | 2021 |
| 34081109 | Equity and the JAMA Network. | JAMA Surg | 2021 |
| 34081104 | Equity and the JAMA Network. | JAMA Otolaryngol Head Neck Surg | 2021 |
| 34081100 | Equity and the JAMA Network. | JAMA | 2021 |
| 34081094 | Equity and the JAMA Network. | JAMA Neurol | 2021 |
| 34081093 | Equity and the JAMA Network. | JAMA Cardiol | 2021 |
| 34081088 | Equity and the JAMA Network. | JAMA Pediatr | 2021 |
| 34081089 | Equity and the JAMA Network. | JAMA Psychiatry | 2021 |
| 34081087 | Equity and the JAMA Network. | JAMA Ophthalmol | 2021 |
| 34081081 | Equity and the JAMA Network. | JAMA Dermatol | 2021 |
| 34081078 | Equity and the JAMA Network. | JAMA Intern Med | 2021 |